Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Mayo Clinic
Mayo Clinic
National Institutes of Health Clinical Center (CC)
Eastern Cooperative Oncology Group
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)